This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Jul 27;326(4):359.

doi: 10.1001/jama.2021.8151.

Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia

Motoharu Shibusawa¹, Keisuke Kidoguchi², Tetsuya Tanimoto³

Affiliations

Affiliations

¹ Department of Hematology, Shinmatsudo Central General Hospital, Chiba, Japan.
² Saga Central Hospital, Saga, Japan.
³ Navitas Clinic Kawasaki, Kanagawa, Japan.

PMID: 34313694
DOI: 10.1001/jama.2021.8151

Comment

Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia

Motoharu Shibusawa et al. JAMA. 2021.

. 2021 Jul 27;326(4):359.

doi: 10.1001/jama.2021.8151.

Authors

Motoharu Shibusawa¹, Keisuke Kidoguchi², Tetsuya Tanimoto³

Affiliations

¹ Department of Hematology, Shinmatsudo Central General Hospital, Chiba, Japan.
² Saga Central Hospital, Saga, Japan.
³ Navitas Clinic Kawasaki, Kanagawa, Japan.

PMID: 34313694
DOI: 10.1001/jama.2021.8151

No abstract available

PubMed Disclaimer

Comment in

Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia-Reply.
Locatelli F, Zugmaier G, von Stackelberg A. Locatelli F, et al. JAMA. 2021 Jul 27;326(4):359-360. doi: 10.1001/jama.2021.8154. JAMA. 2021. PMID: 34313692 No abstract available.

Comment on

Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Locatelli F, Zugmaier G, Rizzari C, Morris JD, Gruhn B, Klingebiel T, Parasole R, Linderkamp C, Flotho C, Petit A, Micalizzi C, Mergen N, Mohammad A, Kormany WN, Eckert C, Möricke A, Sartor M, Hrusak O, Peters C, Saha V, Vinti L, von Stackelberg A. Locatelli F, et al. JAMA. 2021 Mar 2;325(9):843-854. doi: 10.1001/jama.2021.0987. JAMA. 2021. PMID: 33651091 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems